Skip to main content
. 2010 Mar 23;21(10):1999–2004. doi: 10.1093/annonc/mdq065

Figure 2.

Figure 2.

The Kaplan–Meier estimate of overall survival (OS) in the 38 eligible patients with metastatic gastroesophageal junction cancer or gastric cancer enrolled in the study. The dashed lines represent the 95% confidence interval (CI) about each successive estimate of the survival rate. The median OS was 11.1 months (95% CI 8.2–15.3 months). The 12-month OS rate was 40% (95% CI 17% to 63%).